We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Beckman Coulter Launches Automated, High-Throughput DxU Iris Urinalysis Solution in Europe

By LabMedica International staff writers
Posted on 30 Nov 2021

Beckman Coulter, Inc. (Brea, CA, USA) has announced the European launch of the DxU Iris Workcell, a fully-automated system that streamlines urinalysis workflow and reduces manual microscopy.

A routine urinalysis is one the most frequently ordered tests, representing up to 30% of all samples received in the lab. Many of these samples require a lab technician to perform a manual inspection, which causes workflow disruption and a substantial increase in workload. Whether it is confirming the analyzer's findings or identifying unique particle types, manual microscopic reviews are time-consuming and can take up to six times longer per sample than with an automated system. Automating the routine urinalysis workflow with the DxU Iris Workcell reduces sample subjectivity and variability, helping laboratories of all sizes standardize processes, drive faster turnaround time and deliver quality results.


Image: DxU Iris Workcell (Photo courtesy of Beckman Coulter, Inc.)
Image: DxU Iris Workcell (Photo courtesy of Beckman Coulter, Inc.)
Image: DxU Iris Workcell (Photo courtesy of Beckman Coulter, Inc.)

The DxU Iris Workcell pairs the DxU 850m Iris or DxU 840m Iris urine microscopy analyzer with the Arkray AUTION MAX 4030 urine chemistry analyzer to create a scalable, fully automated urinalysis solution. The workcell was developed with proprietary Digital Flow Morphology technology with Auto-Particle Recognition (APR) Software to enable laboratories to deliver standardized results using artificial intelligence (AI). This industry-leading technology isolates, identifies and characterizes urine particles to provide immediate, accurate and reproducible results verified directly on the screen.

"There is no doubt that the pandemic has intensified pressure on the clinical laboratory," said Dr. Peter Soltani, senior vice president & general manager, hematology, urinalysis & workflow information technology solutions at Beckman Coulter. "In this pressurized environment, manual reviews are particularly onerous because they are labor-intensive, taking time and focus away from scientific work. We designed the DxU Iris Workcell to allow urinalysis operators to automatically classify sediment particles, minimizing the need for human intervention."

“We know that it’s important to our customers that any new analyser they bring into the lab makes the workflow better and is easy to use with minimal maintenance,” said Jose Antonio Crespo Solans, Senior Director, EU Sales& Marketing. “With our industry-leading technology operators will be able to isolate, identify, and characterise urine particles to provide immediate, accurate, and reproducible results verified directly on the screen. And with our load-and-go walk away capabilities and EFR technology, we help to minimise operator intervention and interruptions.”

Related Links:
Beckman Coulter, Inc. 


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis

Latest Clinical Chem. News

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring



Sekisui Diagnostics UK Ltd.